Literature DB >> 23768929

Characterization of Escherichia coli O78 from an outbreak of septicemia in lambs in Norway.

Cecilie K Kjelstrup1, Lotte P Stenfors Arnesen, Erik G Granquist, Trine M L'Abée-Lund.   

Abstract

The aim of the study was to characterize isolates of Escherichia coli from an outbreak of septicemia in a Norwegian sheep flock in 2008 with emphasis on virulence, serological grouping, phylogenicity and homology. Six E. coli isolates from succumbed neonatal lambs and four E. coli isolates collected from healthy individuals were analyzed by Pulsed-Field Gel Electrophoresis (PFGE), miniaturized microarray, and polymerase chain reaction (PCR). The septicemic E. coli isolates showed identical pulsotypes (PTs), and belonged to serogroup O78, phylogenetic group A, and MLST ST 369. The virulence genes f17G, bmaE, afaE-VIII, ireA, iroN and iss were detected in the septicemic isolates. The results showed that the E. coli isolates from the septicemic outbreak had a clonal appearance, thus likely originating from a common source. The clone carried genes important for virulence, however, a significant explanation for the high pathogenicity was not revealed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Escherichia coli; Neonatal; Septicemia; Sheep; Virulence

Mesh:

Substances:

Year:  2013        PMID: 23768929     DOI: 10.1016/j.vetmic.2013.05.004

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  2 in total

1.  Genomic avenue to avian colisepticemia.

Authors:  Sagi Huja; Yaara Oren; Eva Trost; Elzbieta Brzuszkiewicz; Dvora Biran; Jochen Blom; Alexander Goesmann; Gerhard Gottschalk; Jörg Hacker; Eliora Z Ron; Ulrich Dobrindt
Journal:  mBio       Date:  2015-01-13       Impact factor: 7.867

2.  Escherichia coli O78 isolated from septicemic lambs shows high pathogenicity in a zebrafish model.

Authors:  Cecilie K Kjelstrup; Amelia E Barber; J Paul Norton; Matthew A Mulvey; Trine M L'Abée-Lund
Journal:  Vet Res       Date:  2017-01-25       Impact factor: 3.683

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.